Clinical Trial

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 8, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
aim of the work 1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia. 2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.
Trial Details
NCT Number NCT07113132
Lead Sponsor Safaa Ali
Conditions Acute Lymphoblastic Leukemia ALL, Chronic Lymphocytic Leukemia (CLL)
Enrollment 84 participants
Start Date 2025-08-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-08